UC-MSC Derived Exosome Therapy

Your cells already know how to heal. Exosome treatment reminds them.

Nanoscale vesicles derived from umbilical cord mesenchymal stem cells, delivering targeted regenerative signals to reduce inflammation, support tissue repair, and restore cellular communication.
What Are Exosomes

Biological messengers, not cells.

Exosomes restore what aging, illness, and chronic inflammation disrupt: the body’s cellular communication network.

Exosomes are extracellular vesicles (EV) — structures cells release naturally as part of how they communicate with each other. Each one carries a precise cargo: proteins, growth factors, lipids, and RNA molecules that instruct nearby cells to reduce inflammation, speed up repair, and restore biological balance.

They’re not cells. They don’t divide or engraft into tissue. Instead, they act as messengers, targeting cells that have lost the ability to communicate effectively, a breakdown that underlies chronic illness, immune dysregulation, and accelerated aging.

At OmniStem, exosomes come exclusively from Wharton’s Jelly-sourced umbilical cord derived exosomes – mesenchymal stem cell exosomes processed in our own GMP-aligned laboratory in Punta Cana, under Ministry of Health oversight.

Why UC-MSC Derived

The source determines the quality.

bioactive markers of uc-msc exosomes
Mesenchymal stem cell (MSC) and secreted exosomes

OmniStem sources exosomes from umbilical cord tissue, specifically Wharton’s Jelly, the connective tissue inside it. This source gives us cells with a low immunogenic profile, high proliferative capacity, and a richer signaling payload than adult-derived alternatives like adipose or bone marrow tissue.

Donor tissue is collected non-invasively, with documented informed consent. Every batch is triple-tested for sterility, viability, and identity before release, and every patient receives a Certificate of Analysis on departure.

The result: a biologic with documented origin, consistent quality, and minimal immune risk, administered under physician supervision, from the same facility where it was produced.

bioactive content of exosomes
Mesenchymal stem cell (MSC) and secreted exosomes
Cellular structure and bioactive components of exosomes
How Exosomes Work

Three mechanisms, one signaling system.

Cellular
Signaling
Exosomes carry microRNA, mRNA, and proteins that communicate directly with target cells — influencing gene expression and calming the inflammatory environment where it’s needed.
Blood-Brain Barrier Penetration
Their nanoscale size (30 to 150 nanometers) lets exosomes cross biological barriers stem cells can’t reach. That’s what makes them particularly relevant for neurological conditions and cognitive support.
Immune
Recalibration
Rather than suppressing immune activity, exosomes help recalibrate it. In autoimmune and chronic inflammatory conditions, that distinction matters clinically.
Therapeutic Benefits

What UC-MSC derived exosomes are designed to support.

Cellular communication

Restores signaling between cells disrupted by aging, stress, or disease.

Inflammation reduction

Targets chronic and systemic inflammatory load without immunosuppression.

Tissue repair

Activates repair processes in joints, discs, pulmonary tissue, and skin.

Neurological support

Delivers regenerative signals across the blood-brain barrier to the central nervous system.

Immune regulation

Helps recalibrate immune activity in chronic inflammatory and autoimmune conditions.

Aesthetic renewal

Stimulates collagen synthesis and follicular activity, supporting skin rejuvenation and hair growth.

Safety profile

The acellular nature of exosomes eliminates replication risk and reduces the chance of immune rejection. As with any biologic, individual side effects are possible, a physician will review these with you as part of your evaluation.

UC-MSCs and Exosomes — How They Differ

Two biologics, one platform.

Both UC-MSC stem cells and their derived exosomes are part of OmniStem’s core biologic platform. They work through different mechanisms and are often combined within the same protocol to amplify therapeutic effect.

UC-MSCs Stem Cells UC-MSC Derived Exosomes Nanoscale Vesicles
Structure Complete cells with nucleus and organelles Nanoscale vesicles — no nucleus, no organelles
Source Wharton's Jelly, umbilical cord Secreted by UC-MSCs during culture
Mechanism Integrate near damaged tissue; secrete anti-inflammatory and regenerative factors Deliver molecular cargo to recipient cells; modulate communication and inflammation
Differentiation Can develop into bone, cartilage, muscle, or fat Do not differentiate — function through signaling only
Immunogenic profile Low Lower — acellular, no replication risk
Blood-brain barrier Does not cross Crosses the BBB; relevant for neurological protocols
Best for Structural tissue repair, systemic regeneration, immune recalibration Neurological support, targeted signaling, aesthetic applications, pulmonary delivery
Characteristic UC-MSCs (Stem Cells) UC-MSC Derived Exosomes
Source Wharton's jelly from the umbilical cord Extracellular vesicles secreted by UC-MSCs
Structure Complete cells with organelles and nucleus Nano-sized vesicles without nucleus, only biomolecules
Differentiation Can transform into various cell types Do not differentiate; act through signaling
Mechanism of Action Integrate and regenerate damaged tissues Modulate cell communication and reduce inflammation
Immunomodulation Secrete anti-inflammatory factors Contain molecules that regulate the immune system
Therapeutic Uses Tissue regeneration in osteoarthritis, neurology, autoimmune diseases, and aesthetics Same therapeutic fields via targeted cell signaling

In many protocols, exosomes are combined with UC-MSC infusions to amplify the regenerative response. Protocol design is determined individually after medical review.

a newer, actively evolving field.

What Makes This a Cutting-Edge Approach

Exosome therapy represents a relatively recent shift in regenerative medicine, moving from whole-cell transplantation toward the signaling molecules those cells naturally produce. This cutting edge approach is still an active area of research, but it offers a meaningful distinction: because exosomes are acellular, they carry a different risk and delivery profile than a full stem cell infusion, while still working through many of the same biological pathways.

The healing process exosomes are designed to support isn’t instantaneous. Like UC-MSC therapy itself, it unfolds gradually as the signaling molecules do their work, most patients are evaluated over a period of weeks to months to track response, not days.

Clinical Applications

Conditions addressed with exosome therapy.

Exosomes are applied across a broad range of clinical indications, delivered as an exosome infusion therapy or via targeted local application depending on the condition. Eligibility is evaluated individually — the conditions below represent where current evidence and clinical experience support their use.

01

Joint Pain & Sports Injuries
Reduces inflammation and supports tissue repair in degenerative joints and ligament injuries, including concussion and post-trauma recovery.

02

Back Pain & Spine Disorders
Targets spinal inflammation and supports regeneration of disc tissue and nerve structures through localized, physician-guided delivery.

03

Neurological & Cognitive Support
Exosomes cross the blood-brain barrier, making them clinically relevant for Alzheimer’s, Parkinson’s, stroke recovery, and cognitive decline.

04

Autoimmune Conditions
Modulates immune activity and reduces systemic inflammation in rheumatoid arthritis, lupus, inflammatory bowel disease, and related conditions.

05

Pulmonary Health
Delivered by nebulization directly to lung tissue, reducing inflammation in COPD, asthma, and post-viral pulmonary conditions.

06

Sexual Wellness
Supports blood flow, nerve regeneration, and tissue health in physician-designed protocols for both men and women.

07

Hair Loss (Alopecia)
Targeted scalp delivery of growth factors and signaling molecules to reactivate dormant follicles and extend hair growth cycles.

08

Healthy Aging & Longevity

Stimulates collagen synthesis, reduces systemic inflammatory load, and supports cellular renewal for patients focused on longevity and quality of life.

Administration

Three routes. One clinical standard.

Exosome delivery method is determined by the condition being treated and the therapeutic objective. All administration is physician-performed under clinical supervision.

Route I

Intravenous Infusion
Systemic distribution for whole-body inflammatory regulation, immune recalibration, and cellular communication support. Used in autoimmune, neurological, and longevity protocols — an exosome IV infusion delivered under physician supervision.

Route II

Targeted Local Application
Concentrated delivery to the point of need — joints, spinal segments, scalp, or facial tissue. Physician-performed, with ultrasound guidance where indicated.

Route III

Nebulization
Direct delivery to pulmonary tissue through inhalation. Applied in respiratory conditions and as part of neurological protocols where rapid systemic uptake supports the therapeutic goal.
FAQ

Frequently Asked Questions

Stem cells are living cells that can divide and develop into different tissue types. Exosomes aren't cells — they're vesicles released by stem cells, carrying growth factors, proteins, and genetic signals. Instead of becoming new tissue, exosomes act as messengers: they help existing cells reduce inflammation, communicate better with each other, and activate repair.
Because exosomes are acellular — they don't divide or engraft — they carry a different risk profile than a full stem cell infusion, including a reduced likelihood of immune rejection. That doesn't mean risk-free: as with any biologic, individual side effects are possible, and suitability depends on your specific condition and health history. A physician evaluation determines which approach, or combination, is appropriate for you.

Yes. At OmniStem, exosomes are frequently used alongside UC-MSC stem cell infusions, hyperbaric oxygen therapy, ozone therapy, and physiotherapy. Combination protocols are designed to amplify the regenerative response. The appropriate combination is determined individually after clinical review.

UC-MSC-derived exosomes carry characteristic surface markers including CD9, CD63, CD81, CD73, CD90, and CD105, along with a cargo of microRNA, mRNA, structural proteins, and bioactive lipids. Identity characterization is part of our triple-testing protocol for every batch.

Results tend to build gradually rather than appear immediately, since exosomes work by supporting the body's own repair process rather than providing instant relief. Timelines vary by condition and individual response — your physician will discuss what to expect for your specific protocol.

This depends on the condition, its severity, and individual clinical response. Some patients achieve their therapeutic objectives with a single treatment. Others benefit from follow-up sessions. The medical team monitors progress and makes recommendations based on your response to the initial protocol and your long-term clinical goals.

These therapies are available in the Dominican Republic under physician supervision and Ministry of Health oversight. They are not currently approved for clinical use in the United States or European Union. OmniStem operates within a regulated legal framework, and is located minutes from Punta Cana International Airport, with concierge coordination for reception, transport, and accommodation throughout your stay.

BEGIN YOUR EVALUATION

Your case. In our hands.
Within 48 hours.

A physician on the OmniStem medical team will review your clinical profile individually and prepare an initial assessment. What follows is a medical conversation, no obligation.